Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 54

Sort by

Sort Order Select

Journal Articles

Abstract 2053: Mechanisms of resistance to palbociclib and aromatase inhibitors in hormone receptor positive breast cancer

Armina A. Kazi, Antony Sare, Saranya Chumsri, Angela Brodie

Cancer Res (2017) 77 (13_Supplement): 2053.

https://doi.org/10.1158/1538-7445.AM2017-2053

Published: 01 July 2017

View article titled, Abstract 2053: Mechanisms of resistance to palbociclib and aromatase inhibitors in hormone receptor positive breast cancer

Journal Articles

Abstract 3604: Effect of a new oral SERD AZD9496 on ER mediated signaling in xenograft model of postmenopausal breast cancer

Gauri J. Sabnis, Armina Kazi, Amanda Schech, Stephen Yu, Olga Golubeva, Angela Brodie

Cancer Res (2017) 77 (13_Supplement): 3604.

https://doi.org/10.1158/1538-7445.AM2017-3604

Published: 01 July 2017

View article titled, Abstract 3604: Effect of a new oral SERD AZD9496 on ER mediated signaling in xenograft model of postmenopausal breast cancer

Journal Articles

Abstract 1062: Overexpression of miRNAs 181a and 222 play a role in triple negative breast cancer, and are targeted by entinostat

Armina A. Kazi, Alexa Giammarino, Nicholas Musacchio, Gauri Sabnis, Amanda Schech, Angela Brodie

Cancer Res (2016) 76 (14_Supplement): 1062.

https://doi.org/10.1158/1538-7445.AM2016-1062

Published: 15 July 2016

View article titled, Abstract 1062: Overexpression of miRNAs 181a and 222 play a role in triple negative breast cancer, and are targeted by entinostat

Journal Articles

Combined Treatment with Epigenetic, Differentiating, and Chemotherapeutic Agents Cooperatively Targets Tumor-Initiating Cells in Triple-Negative Breast Cancer

Cancer Res (2016) 76 (7): 2013–2024.

https://doi.org/10.1158/0008-5472.CAN-15-1619

Published: 31 March 2016

View article titled, Combined Treatment with Epigenetic, Differentiating, and Chemotherapeutic Agents Cooperatively Targets Tumor-Initiating Cells in Triple-Negative Breast Cancer

Includes: Supplementary data

Journal Articles

Abstract P3-05-06: A nude mouse model of diet-induced-obesity to study the mechanisms of resistance to aromatase inhibitor letrozole in MCF-7Ca xenografts

Amanda Schech, Stephen Yu, Preeti Shah, Olga Goloubeva, Angela Brodie, Saranya Chumsri, Gauri Sabnis

Cancer Res (2015) 75 (9_Supplement): P3-05-06.

https://doi.org/10.1158/1538-7445.SABCS14-P3-05-06

Published: 01 May 2015

View article titled, Abstract P3-05-06: A nude mouse model of diet-induced-obesity to study the mechanisms of resistance to aromatase inhibitor letrozole in MCF-7Ca xenografts

Journal Articles

Abstract 621: Effect of diet-induced obesity on MCF-7Ca xenografts grown in ovariectomized athymic nude mice

Gauri J. Sabnis, Olga Goloubeva, Preeti Shah, Saranya Chumsri, Angela Brodie

Cancer Res (2014) 74 (19_Supplement): 621.

https://doi.org/10.1158/1538-7445.AM2014-621

Published: 01 October 2014

View article titled, Abstract 621: Effect of diet-induced obesity on MCF-7Ca xenografts grown in ovariectomized athymic nude mice

Journal Articles

Abstract 1471: HER2 regulated miRNA expression in letrozole resistant breast cancer

Armina A. Kazi, Gauri Sabnis, Qun Zhou, Saranya Chumsri, Amanda Schech, Preeti Shah, Angela Brodie

Cancer Res (2014) 74 (19_Supplement): 1471.

https://doi.org/10.1158/1538-7445.AM2014-1471

Published: 01 October 2014

View article titled, Abstract 1471: HER2 regulated miRNA expression in letrozole resistant breast cancer

Journal Articles

Abstract 1072: MM-121/SAR256212, an anti-ErbB3 antibody, restores sensitivity to letrozole and delays the onset of resistance in an ER+ breast cancer model.

Michael D. Curley, Gauri Sabnis, Lucia Wille, Gabriela Garcia, Victor Moyo, Armina Kazi, Gavin MacBeath, Angela Brodie

Cancer Res (2013) 73 (8_Supplement): 1072.

https://doi.org/10.1158/1538-7445.AM2013-1072

Published: 15 April 2013

View article titled, Abstract 1072: MM-121/SAR256212, an anti-ErbB3 antibody, restores sensitivity to letrozole and delays the onset of resistance in an ER+ breast cancer model.

Journal Articles

Abstract 95: Inhibiiton of non-hypoxic HIF-1 expression in letrozole-resistant breast cancer cells reduces their cancer stem cell characteristics.

Armina A. Kazi, Preeti Shah, Amanda Schech, Gauri Sabnis, Saranya Chumsri, Angela Brodie

Cancer Res (2013) 73 (8_Supplement): 95.

https://doi.org/10.1158/1538-7445.AM2013-95

Published: 15 April 2013

View article titled, Abstract 95: Inhibiiton of non-hypoxic HIF-1 expression in letrozole-resistant breast cancer cells reduces their cancer stem cell characteristics.

Journal Articles

Abstract 1314: HDAC inhibitor entinostat reverses letrozole resistance in MCF-7Ca xenografts through modulation of Her-2.

Gauri J. Sabnis, Armina Kazi, Olga Goloubeva, Saranya Chumsri, Angela Brodie

Cancer Res (2013) 73 (8_Supplement): 1314.

https://doi.org/10.1158/1538-7445.AM2013-1314

Published: 15 April 2013

View article titled, Abstract 1314: HDAC inhibitor entinostat reverses letrozole resistance in MCF-7Ca xenografts through modulation of Her-2.

Journal Articles

Abstract 1311: Preclinical assessment of an HDAC inhibitor combined with a retinoid in AI resistant breast cancer.

Preeti Shah, Gauri J. Sabnis, Olga Goloubeva, Armina Kazi, Amanda Schech, Rabia Gilani, Yael Gau, Saranya Chumsri, Angela Brodie

Cancer Res (2013) 73 (8_Supplement): 1311.

https://doi.org/10.1158/1538-7445.AM2013-1311

Published: 15 April 2013

View article titled, Abstract 1311: Preclinical assessment of an HDAC inhibitor combined with a retinoid in AI resistant breast cancer.

Journal Articles

Abstract 1778: C-MYC plays a novel role in driving the error-prone double-strand break repair in triple negative breast cancers.

Pratik K. Nagaria, Khadiza Chowdhury, Angela Brodie, Feyruz Rassool

Cancer Res (2013) 73 (8_Supplement): 1778.

https://doi.org/10.1158/1538-7445.AM2013-1778

Published: 15 April 2013

View article titled, Abstract 1778: C-MYC plays a novel role in driving the error-prone double-strand break repair in triple negative breast cancers.

Journal Articles

Abstract 787: Involvement of HER2, HIF-1, and BCRP in cancer stem cell characteristics of letrozole-resistant breast cancer cells

Rabia Gilani, Armina A. Kazi, Amanda Scheh, Saranya Chumsri, Preeti Shah, Angela Brodie

Cancer Res (2012) 72 (8_Supplement): 787.

https://doi.org/10.1158/1538-7445.AM2012-787

Published: 15 April 2012

View article titled, Abstract 787: Involvement of HER2, HIF-1, and BCRP in cancer stem cell characteristics of letrozole-resistant breast cancer cells

Journal Articles

Abstract 2919: Effect of selumetinib and AZD8055 on the growth of anastrozole resistant tumors

Gauri J. Sabnis, Armina Kazi, Olga Goloubeva, Amanda Schech, Preeti Shah, Bob Zhang, Angela Brodie

Cancer Res (2012) 72 (8_Supplement): 2919.

https://doi.org/10.1158/1538-7445.AM2012-2919

Published: 15 April 2012

View article titled, Abstract 2919: Effect of selumetinib and AZD8055 on the growth of anastrozole resistant tumors

Journal Articles

Dual IGF-1R/InsR Inhibitor BMS-754807 Synergizes with Hormonal Agents in Treatment of Estrogen-Dependent Breast Cancer

Xiaonan Hou, Fei Huang, Luciana F. Macedo, Sean C. Harrington, Karen A. Reeves, Ann Greer, Friedrich Graf Finckenstein, Angela Brodie, Marco M. Gottardis, Joan M. Carboni, Paul Haluska

Cancer Res (2011) 71 (24): 7597–7607.

https://doi.org/10.1158/0008-5472.CAN-11-1080

Published: 15 December 2011

View article titled, Dual IGF-1R/InsR Inhibitor BMS-754807 Synergizes with Hormonal Agents in Treatment of Estrogen-Dependent Breast Cancer

Includes: Supplementary data

Journal Articles

Abstract 3230: In vitro evaluation of Her2 targeted N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer conjugates in combination treatment with tyrosine kinase inhibitor (PKI-166)

Jun H. Lee, Gauri Sabnis, Angela Brodie, Anjan Nan

Cancer Res (2011) 71 (8_Supplement): 3230.

https://doi.org/10.1158/1538-7445.AM2011-3230

Published: 15 April 2011

View article titled, Abstract 3230: In vitro evaluation of Her2 targeted N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer conjugates in combination treatment with tyrosine kinase inhibitor (PKI-166)

Journal Articles

Abstract 2295: Regulation of Her-2 in long-term letrozole resistant cells by HSP-90

Gauri J. Sabnis, Armina Kazi, Angela Brodie

Cancer Res (2011) 71 (8_Supplement): 2295.

https://doi.org/10.1158/1538-7445.AM2011-2295

Published: 15 April 2011

View article titled, Abstract 2295: Regulation of Her-2 in long-term letrozole resistant cells by HSP-90

Journal Articles

Abstract 1472: MRP4 and PGT, members of the COX-2 pathway, may contribute to breast cancer progression

Tyler Kochel, Namita Kundu, Xinrong Ma, Jocelyn Reader, Angela Brodie, Amy M. Fulton

Cancer Res (2011) 71 (8_Supplement): 1472.

https://doi.org/10.1158/1538-7445.AM2011-1472

Published: 15 April 2011

View article titled, Abstract 1472: MRP4 and PGT, members of the COX-2 pathway, may contribute to breast cancer progression

Journal Articles

Abstract 5495: ALT NHEJ is a therapeutic target in hormone therapy resistant ER/PR/HER+ and ER/PR/HER- breast cancers

Lisa A. Tobin, Saranya Chumsri, Paul Staats, Angela Brodie, Alan Tomkinson, Feyruz Rassool

Cancer Res (2011) 71 (8_Supplement): 5495.

https://doi.org/10.1158/1538-7445.AM2011-5495

Published: 15 April 2011

View article titled, Abstract 5495: ALT NHEJ is a therapeutic target in hormone therapy resistant ER/PR/HER+ and ER/PR/HER- breast cancers

Journal Articles

Abstract 4596: Restoring hypoxia-inducible factor-1α in MCF-7 breast cancer cells in vitro by preventing the excessive degradation induced by high oxygen unmasks strong estradiol induction of vascular endothelial growth factor expression

Kristin H. Molitoris, Angela Brodie, Robert D. Koos

Cancer Res (2010) 70 (8_Supplement): 4596.

https://doi.org/10.1158/1538-7445.AM10-4596

Published: 15 April 2010

View article titled, Abstract 4596: Restoring hypoxia-inducible factor-1α in MCF-7 breast cancer cells in vitro by preventing the excessive degradation induced by high oxygen unmasks strong estradiol induction of vascular endothelial growth factor expression

NARROW

Abstract 2053: Mechanisms of resistance to palbociclib and aromatase inhibitors in hormone receptor positive breast cancer

Abstract 3604: Effect of a new oral SERD AZD9496 on ER mediated signaling in xenograft model of postmenopausal breast cancer

Abstract 1062: Overexpression of miRNAs 181a and 222 play a role in triple negative breast cancer, and are targeted by entinostat

Combined Treatment with Epigenetic, Differentiating, and Chemotherapeutic Agents Cooperatively Targets Tumor-Initiating Cells in Triple-Negative Breast Cancer

Abstract P3-05-06: A nude mouse model of diet-induced-obesity to study the mechanisms of resistance to aromatase inhibitor letrozole in MCF-7Ca xenografts

Abstract 621: Effect of diet-induced obesity on MCF-7Ca xenografts grown in ovariectomized athymic nude mice

Abstract 1471: HER2 regulated miRNA expression in letrozole resistant breast cancer

Abstract 1072: MM-121/SAR256212, an anti-ErbB3 antibody, restores sensitivity to letrozole and delays the onset of resistance in an ER+ breast cancer model.

Abstract 95: Inhibiiton of non-hypoxic HIF-1 expression in letrozole-resistant breast cancer cells reduces their cancer stem cell characteristics.

Abstract 1314: HDAC inhibitor entinostat reverses letrozole resistance in MCF-7Ca xenografts through modulation of Her-2.

Abstract 1311: Preclinical assessment of an HDAC inhibitor combined with a retinoid in AI resistant breast cancer.

Abstract 1778: C-MYC plays a novel role in driving the error-prone double-strand break repair in triple negative breast cancers.

Abstract 787: Involvement of HER2, HIF-1, and BCRP in cancer stem cell characteristics of letrozole-resistant breast cancer cells

Abstract 2919: Effect of selumetinib and AZD8055 on the growth of anastrozole resistant tumors

Dual IGF-1R/InsR Inhibitor BMS-754807 Synergizes with Hormonal Agents in Treatment of Estrogen-Dependent Breast Cancer

Abstract 3230: In vitro evaluation of Her2 targeted N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer conjugates in combination treatment with tyrosine kinase inhibitor (PKI-166)

Abstract 2295: Regulation of Her-2 in long-term letrozole resistant cells by HSP-90

Abstract 1472: MRP4 and PGT, members of the COX-2 pathway, may contribute to breast cancer progression

Abstract 5495: ALT NHEJ is a therapeutic target in hormone therapy resistant ER/PR/HER+ and ER/PR/HER- breast cancers

Abstract 4596: Restoring hypoxia-inducible factor-1α in MCF-7 breast cancer cells in vitro by preventing the excessive degradation induced by high oxygen unmasks strong estradiol induction of vascular endothelial growth factor expression

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only